These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 16651811)

  • 41. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
    Allahtavakoli M; Moloudi R; Arababadi MK; Shamsizadeh A; Javanmardi K
    Brain Res; 2009 May; 1271():121-7. PubMed ID: 19332033
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuroprotective effect of 5,7,3',4',5'-pentahydroxy dihydroflavanol-3-O-(2''-O-galloyl)-beta-D-glucopyranoside, a polyphenolic compound in focal cerebral ischemia in rat.
    ArunaDevi R; Lata S; Bhadoria BK; Ramteke VD; Kumar S; Sankar P; Kumar D; Tandan SK
    Eur J Pharmacol; 2010 Jan; 626(2-3):205-12. PubMed ID: 19782680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of HMG-CoA reductase inhibition on brain pathology.
    Zipp F; Waiczies S; Aktas O; Neuhaus O; Hemmer B; Schraven B; Nitsch R; Hartung HP
    Trends Pharmacol Sci; 2007 Jul; 28(7):342-9. PubMed ID: 17573124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Do statins afford neuroprotection in patients with cerebral ischaemia and stroke?
    Vaughan CJ; Delanty N; Basson CT
    CNS Drugs; 2001; 15(8):589-96. PubMed ID: 11524031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A sartan derivative with a very low angiotensin II receptor affinity ameliorates ischemic cerebral damage.
    Takizawa S; Dan T; Uesugi T; Nagata E; Takagi S; van Ypersele de Strihou C; Miyata T
    J Cereb Blood Flow Metab; 2009 Oct; 29(10):1665-72. PubMed ID: 19536069
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting the brain: neuroprotection and neurorestoration in ischemic stroke.
    Saver JL
    Pharmacotherapy; 2010 Jul; 30(7 Pt 2):62S-9S. PubMed ID: 20575624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator.
    Zhang L; Zhang ZG; Liu X; Hozeska A; Stagliano N; Riordan W; Lu M; Chopp M
    Thromb Haemost; 2006 Jan; 95(1):166-73. PubMed ID: 16543976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiplatelets, ACE inhibitors, and statins combination reduces stroke severity and tissue at risk.
    Kumar S; Savitz S; Schlaug G; Caplan L; Selim M
    Neurology; 2006 Apr; 66(8):1153-8; discussion 1135. PubMed ID: 16636230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oxidative stress and endothelial dysfunction: therapeutic implications.
    Gori T; Münzel T
    Ann Med; 2011 Jun; 43(4):259-72. PubMed ID: 21284528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protective effects of angiotensin II interruption: evidence for antiinflammatory actions.
    Dagenais NJ; Jamali F
    Pharmacotherapy; 2005 Sep; 25(9):1213-29. PubMed ID: 16164395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats.
    Tanaka N; Katayama Y; Katsumata T; Otori T; Nishiyama Y
    Brain Res; 2007 Sep; 1169():125-32. PubMed ID: 17706949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potential novel pharmacological therapies for myocardial remodelling.
    Landmesser U; Wollert KC; Drexler H
    Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oxaloacetate: a novel neuroprotective for acute ischemic stroke.
    Campos F; Sobrino T; Ramos-Cabrer P; Castillo J
    Int J Biochem Cell Biol; 2012 Feb; 44(2):262-5. PubMed ID: 22085530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological treatment of ischemic stroke.
    Bentley P; Sharma P
    Pharmacol Ther; 2005 Dec; 108(3):334-52. PubMed ID: 16135384
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neu2000, an NR2B-selective, moderate NMDA receptor antagonist and potent spin trapping molecule for stroke.
    Cho SI; Park UJ; Chung JM; Gwag BJ
    Drug News Perspect; 2010 Nov; 23(9):549-56. PubMed ID: 21152450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of statins on ischemic stroke: neuroprotection and/or triggering of apoptotic damage?
    Duval D
    Stroke; 2000 Apr; 31(4):989-90. PubMed ID: 10754014
    [No Abstract]   [Full Text] [Related]  

  • 58. Role of the vascular endothelium and plaque in acute ischemic stroke.
    Madden JA
    Neurology; 2012 Sep; 79(13 Suppl 1):S58-62. PubMed ID: 23008414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel therapeutic strategies targeting vascular redox in human atherosclerosis.
    Antonopoulos AS; Antoniades C; Tousoulis D; Bakogiannis C; Demosthenous M; Psarros C; Stefanadis C
    Recent Pat Cardiovasc Drug Discov; 2009 Jun; 4(2):76-87. PubMed ID: 19519550
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The role of sex steroids in prevention of post-ischaemic brain injury].
    Pakulski C
    Anestezjol Intens Ter; 2011; 43(3):186-9. PubMed ID: 22011925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.